Login

CEO Andreas Thorsheim presents Otovo, a Norwegian startup offering a residential solar and battery marketplace, at Ecosummit Berlin 2023. 00:10:00

Share On Facebook Share On Twitter

Andreas Thorsheim is the Founder and CEO at Otovo 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Why Market is the Most Important Factor|Saar Gur,partner,CRV
00:10:00
Inside All for One Steeb. Interview mit Serkar | Lars Landwehrkamp, CEO, All for One Group SEA1OSX:GER
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses her company's strategy and initiatives on 'Squawk Box'.
00:10:00
Future Predictions and Investment Strategies in Energy Transition: Insights from Pacific Road Capital
00:10:00
Orlando Bravo: Architect of Success at Thoma Bravo | Orlando Bravo, Founder, Thoma Bravo.
00:10:00
CEO discusses plans to transition to a true corporation, focusing on decarbonization, ESG initiatives, and ambitious growth targets | Daniel Pimentel Slaviero, CEO, Companhia Paranaense de Energia.
00:10:00
Strategic Social Security Planning: Insights with Jim Heafner and Myron Kandel - Jim Heafner | President | Heafner Financial Solutions, Inc.
00:10:00
In-depth discussion on neuro therapeutics and strategic priorities for the next 18 months by Actinogen Medical Ltd CEO|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:00:00
ONCIMMUNE HOLDINGS PLC - Investor Presentation - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:10:00
AdEPT Technology Group reintroduces interim dividend | Robert Bucher, CEO, AdEPT Technology Group PLCADT:LSE
00:10:00
Gianmarco Lanza, CEO of FAE Technology SB S.p.A., will be the guest speaker at the upcoming free Smart Webinar.
00:10:00
A Strategic Growth Pillar for Fill Invest Development Group's Diversification Strategy| Josephine Gotianun Yap , CEO, Filinvest Development Corp.

© 2017 - Neuhu+